Chetan Bipinchandra Shah's Insider Trades & SAST Disclosures
Chetan Bipinchandra Shah's most recent trade in Senores Pharmaceuticals Ltd. was a Acquisition of 550 Equity Shares done at an average price of Rs. 564.4 . Disclosure was reported to the exchange on March 13, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Chetan Bipinchandra Shah in the Trendlyne database.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Chetan Bipinchandra Shah.To see full superstar portfolios of large investors like Jhunjhunwala, Damani and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 13 Mar 2025 | 550 | 3,550 (0.01%) | 0.00% | 564.4 | 310,415 | 12 Mar 2025 12 Mar 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 27 Feb 2025 | 1,000 | 3,000 (0%) | 0.00% | 561.8 | 561,830 | 25 Feb 2025 25 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 27 Feb 2025 | 1,000 | 2,000 (0%) | 0.00% | 552.4 | 552,360 | 24 Feb 2025 24 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 46 | 819 (0%) | 0.00% | 522.3 | 24,026 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 34 | 184 (0%) | 0.00% | 521.6 | 17,736 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 142 | 984 (0%) | 0.00% | 522.4 | 74,181 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 298 | 522 (0%) | 0.00% | 521.9 | 155,541 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 23 | 565 (0%) | 0.00% | 522.1 | 12,008 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 76 | 773 (0%) | 0.00% | 522.3 | 39,691 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 29 | 214 (0%) | 0.00% | 521.8 | 15,132 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 23 | 842 (0%) | 0.00% | 522.3 | 12,014 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 95 | 660 (0%) | 0.00% | 522.1 | 49,604 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 10 | 224 (0%) | 0.00% | 521.9 | 5,219 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 37 | 697 (0%) | 0.00% | 522.2 | 19,321 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 1 | 185 (0%) | 0.00% | 522 | 522 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 20 | 542 (0%) | 0.00% | 522.1 | 10,441 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 16 | 1,000 (0%) | 0.00% | 522.4 | 8,359 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.